BeyondSpring Inc. (BYSI) income statement
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.44−0.02 (-3.53%)
Close on Nov 19, 2026Market cap $17.97MP/E –Yield –
BeyondSpring Inc. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $17.97MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||
| Operating margin | – | – | – | -2,756.4% | -4,903.0% | -35,672.8% | – | – | – | – | – | – | – |
| Pre-tax margin | – | – | – | -2,673.4% | -4,784.5% | -35,456.1% | – | – | – | – | – | – | – |
| Net profit margin | – | – | – | -2,463.3% | -4,750.5% | -33,873.9% | – | – | – | – | – | – | – |
| Free cash flow margin | – | – | – | -2,086.2% | -3,707.3% | -24,331.7% | – | – | – | – | – | – | – |
| Returns on capital | |||||||||||||
| Return on equity | 3.1% | 37.3% | 128.3% | -321.5% | -111.6% | -102.8% | -338.4% | -568.3% | -467.8% | -113.8% | 3,598.2% | 36.0% | – |
| Return on assets | -3.3% | -37.6% | -59.2% | -52.1% | -64.6% | -75.5% | -147.6% | -275.1% | -384.5% | -92.8% | -72.7% | – | – |
| Return on tangible assets | -3.3% | -37.6% | -59.2% | -52.1% | -64.6% | -75.5% | -147.6% | -275.1% | -384.5% | -92.8% | -72.7% | – | – |
| Return on invested capital | – | – | – | 58.1% | 148.2% | 420.8% | 946.0% | – | – | – | – | – | – |
| Return on capital employed | -50.2% | -43.6% | -54.1% | -70.7% | -78.0% | -93.2% | -320.9% | -617.0% | -485.8% | -112.7% | -77.4% | – | – |
| Return on total capital | – | – | – | -885.5% | -119.0% | -105.8% | -123.8% | – | – | – | – | – | – |
| NOPAT | -$7.07M | -$6.92M | -$11.91M | -$29.42M | -$52.33M | -$50.73M | -$31.84M | -$45.46M | -$77.40M | -$9.77M | -$5.91M | -$1.67M | – |
| Cash flow quality | |||||||||||||
| OCF / Sales | – | – | – | -2,083.7% | -3,496.8% | -24,302.8% | – | – | – | – | – | – | – |
| OCF / Net income | 19.65 | 1.48 | 0.78 | 0.85 | 0.74 | 0.72 | 1.26 | 0.73 | 0.31 | 1.14 | 0.82 | 0.38 | – |
| FCF / OCF | 100.3% | 101.4% | 100.6% | 100.1% | 106.0% | 100.1% | 100.0% | 100.5% | 100.3% | 100.5% | 100.6% | – | – |
| FCF / Net income | 19.70 | 1.50 | 0.79 | 0.85 | 0.78 | 0.72 | 1.26 | 0.73 | 0.31 | 1.15 | 0.83 | – | – |
| Unlevered free cash flow | -$19.82M | -$16.67M | -$16.57M | -$28.17M | -$50.02M | -$43.73M | -$48.00M | -$40.16M | -$28.87M | -$13.76M | -$6.19M | – | – |
| Levered free cash flow | -$19.82M | -$16.67M | -$16.57M | -$28.19M | -$50.09M | -$43.80M | -$48.17M | -$40.16M | -$28.87M | -$13.76M | -$6.61M | – | – |
| Efficiency | |||||||||||||
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – |
| Fixed asset turnover | 0.00 | 0.00 | 0.00 | 0.82 | 1.68 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – |
| CapEx to revenue | – | – | – | 2.5% | 210.5% | 28.9% | – | – | – | – | – | – | – |
| CapEx to OCF | -0.25% | -1.4% | -0.61% | -0.12% | -6.0% | -0.12% | -0.01% | -0.52% | -0.26% | -0.47% | -0.61% | – | – |
| Liquidity | |||||||||||||
| Current ratio | 1.54 | 2.60 | 2.31 | 5.24 | 4.96 | 8.24 | 4.06 | 0.36 | 6.75 | 5.64 | 8.34 | – | – |
| Quick ratio | 1.54 | 2.60 | 2.31 | 5.24 | 4.96 | 8.24 | 4.06 | 0.36 | 6.75 | 5.64 | 8.34 | – | – |
| Cash ratio | 0.93 | 0.27 | 2.25 | 5.07 | 4.78 | 7.96 | 3.57 | 0.24 | 6.38 | 4.48 | 8.25 | – | – |
| Working capital | $7.31M | $17.57M | $10.46M | $31.17M | $59.97M | $99.63M | $30.81M | -$10.57M | $27.55M | $12.10M | $9.62M | – | – |
| Net current asset value | -$29.04M | -$20.02M | -$29.85M | -$10.71M | $19.85M | $88.18M | $27.44M | -$10.57M | $27.55M | $12.10M | $9.62M | – | – |
| Leverage | |||||||||||||
| Total debt | – | – | – | $0 | $1.57M | $2.17M | $1.44M | – | – | – | – | – | – |
| Net debt | – | – | – | -$37.27M | -$70.80M | -$107.37M | -$34.50M | – | – | – | – | – | – |
| Debt / Equity | – | – | – | -0.00 | 0.06 | 0.02 | 0.05 | – | – | – | – | – | – |
| Debt ratio | – | – | – | 0.00% | 1.9% | 1.9% | 3.2% | – | – | – | – | – | – |
| Assets to equity | -0.81 | -1.04 | -0.93 | -7.73 | 3.06 | 1.32 | 1.47 | -0.91 | 1.21 | 1.23 | 1.23 | – | – |
| Long-term debt to assets | – | – | – | – | 0.00% | 1.9% | 3.2% | – | – | – | – | – | – |
| Long-term debt to equity | – | – | – | – | 0.00 | 0.02 | 0.05 | – | – | – | – | – | – |
| Total debt / Capitalization | – | – | – | -0.00% | 5.6% | 2.4% | 4.5% | – | – | – | – | – | – |
| Long-term debt / Capitalization | – | – | – | – | 0.00% | 2.4% | 4.5% | – | – | – | – | – | – |
| Cash flow to debt | – | – | – | – | -3,011.0% | -2,018.7% | -3,353.9% | – | – | – | – | – | – |
| Interest coverage | |||||||||||||
| EBIT / Interest expense | – | – | – | -2,190.53 | -761.38 | -755.42 | -195.67 | – | – | – | -14.05 | -2.55 | – |
| Per share | |||||||||||||
| Revenue per share | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.0046 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – |
| EPS (basic) | -0.02 | -0.28 | -0.54 | -0.85 | -1.64 | -2.03 | -1.55 | -2.42 | -4.40 | -0.75 | -0.53 | -0.22 | – |
| EPS (diluted) | – | – | – | – | -1.64 | -2.03 | -1.55 | -2.42 | -4.40 | -0.75 | -0.53 | -0.22 | – |
| Book value per share | -0.78 | -0.82 | -0.69 | -0.15 | 0.69 | 2.26 | 1.09 | -0.33 | 1.20 | 0.72 | 0.57 | -0.68 | – |
| Tangible book value per share | -0.78 | -0.82 | -0.69 | -0.15 | 0.69 | 2.26 | 1.09 | -0.33 | 1.20 | 0.72 | 0.57 | -0.68 | – |
| Cash per share | 0.31 | 0.07 | 0.46 | 0.96 | 1.86 | 2.80 | 1.29 | 0.17 | 1.36 | 0.69 | 0.69 | 0.03 | – |
| Operating cash flow per share | -0.48 | -0.41 | -0.42 | -0.72 | -1.21 | -1.12 | -1.73 | -1.72 | -1.28 | -0.81 | -0.42 | -0.08 | – |
| Free cash flow per share | -0.48 | -0.41 | -0.42 | -0.72 | -1.29 | -1.12 | -1.73 | -1.73 | -1.28 | -0.82 | -0.42 | – | – |
| CapEx per share | 0.0012 | 0.0056 | 0.0026 | 0.0009 | 0.07 | 0.0013 | 0.0001 | 0.0089 | 0.0034 | 0.0038 | 0.0025 | – | – |
| Valuation at period end | |||||||||||||
| Market cap | $67.03M | $65.69M | $35.11M | $73.24M | $177.31M | $372.30M | $402.44M | $434.53M | $664.31M | – | – | – | – |
| Enterprise value | $66.37M | $46.74M | $11.65M | $14.25M | $82.74M | $342.41M | $380.97M | $412.03M | $624.94M | – | – | – | – |
| P/S | – | – | – | 54.2x | 131x | 2,068x | – | – | – | – | – | – | – |
| P/B | -2.1x | -2.0x | -1.3x | -12.2x | 6.6x | 4.2x | 13.3x | -56.0x | 24.5x | – | – | – | – |
| P/TBV | -2.1x | -2.0x | -1.3x | -12.2x | 6.6x | 4.2x | 13.3x | -56.0x | 24.5x | – | – | – | – |
| P/OCF | -3.4x | -4.0x | -2.1x | -2.6x | -3.8x | -8.5x | -8.4x | -10.9x | -23.1x | – | – | – | – |
| EV/Sales | – | – | – | 10.5x | 61.2x | 1,902x | – | – | – | – | – | – | – |
| EV/OCF | -3.4x | -2.8x | -0.7x | -0.5x | -1.8x | -7.8x | -7.9x | -10.3x | -21.7x | – | – | – | – |
| Earnings yield | -1.5% | -16.9% | -59.9% | -45.4% | -36.2% | -16.4% | -9.5% | -12.6% | -13.8% | – | – | – | – |
| FCF yield | -29.6% | -25.4% | -47.2% | -38.5% | -28.2% | -11.8% | -12.0% | -9.2% | -4.3% | – | – | – | – |
| Cost structure | |||||||||||||
| R&D to revenue | – | – | – | 1,893.6% | 2,730.4% | 23,218.3% | – | – | – | – | – | – | – |
| SG&A to revenue | – | – | – | 962.8% | 2,272.6% | 12,554.4% | – | – | – | – | – | – | – |
| Stock-based comp to revenue | – | – | – | 123.3% | 233.3% | 4,552.2% | – | – | – | – | – | – | – |
| Per employee | |||||||||||||
| Total employees | 44 | 40 | 36 | 73 | 103 | 91 | 61 | 52 | 38 | 25 | 25 | 25 | 25 |
| Revenue per employee | $0 | $0 | $0 | $18.51K | $13.12K | $1.98K | $0 | – | $0 | $0 | $0 | $0 | – |
| Operating profit per employee | -$203.30K | -$218.85K | -$418.92K | -$510.12K | -$643.11K | -$705.62K | -$660.77K | -$1.11M | -$2.58M | -$494.72K | -$299.00K | -$84.36K | – |
| Net income per employee | -$22.86K | -$278.08K | -$584.06K | -$455.88K | -$623.10K | -$670.03K | -$624.34K | -$1.06M | -$2.41M | -$480.40K | -$318.80K | -$120.52K | – |
| Free cash flow per employee | -$450.43K | -$416.68K | -$460.39K | -$386.10K | -$486.27K | -$481.29K | -$789.61K | -$772.35K | -$759.79K | -$550.48K | -$264.40K | – | – |
| Growth | |||||||||||||
| Revenue 1Y growth | – | – | -100.0% | 0.00% | 650.6% | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -2.2% | 42.0% | 59.5% | 43.8% | -3.2% | -59.3% | 30.0% | 41.3% | -692.2% | -65.5% | -254.4% | – | – |
| Net income 1Y growth | 91.0% | 47.1% | 36.8% | 48.1% | -5.3% | -60.1% | 30.6% | 40.2% | -664.1% | -50.7% | -164.5% | – | – |
| Diluted EPS 1Y growth | – | – | – | – | 19.2% | -31.0% | 36.0% | 45.0% | -486.7% | -41.5% | -140.9% | – | – |
| Operating cash flow 1Y growth | -20.2% | 0.19% | 41.5% | 40.4% | -8.0% | 9.2% | -20.5% | -38.8% | -110.2% | -108.5% | -473.3% | – | – |
| Free cash flow 1Y growth | -18.9% | -0.56% | 41.2% | 43.7% | -14.4% | 9.1% | -19.9% | -39.1% | -109.8% | -108.2% | – | – | – |
| CapEx 1Y growth | -77.7% | 124.0% | 194.1% | -98.8% | 5,369.2% | 1,200.0% | -98.1% | 172.4% | 18.8% | 60.0% | – | – | – |
| CapEx 3Y CAGR | 13.7% | -57.1% | 24.4% | 104.1% | 139.5% | -11.9% | -60.3% | 73.0% | – | – | – | – | – |
| CapEx 5Y CAGR | -0.78% | 123.7% | -13.5% | -14.9% | 113.6% | 5.4% | – | – | – | – | – | – | – |
| CapEx 10Y CAGR | 2.3% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -24.4% | 38.3% | -46.3% | -43.4% | -30.2% | 162.7% | 530.8% | -78.5% | 120.2% | 35.9% | – | – | – |
| Total assets 3Y CAGR | -17.5% | -25.1% | -40.4% | 1.2% | 126.1% | 52.8% | 44.0% | -13.7% | – | – | – | – | – |
| Total assets 5Y CAGR | -26.0% | -5.1% | 28.6% | 7.1% | 40.5% | 60.6% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 9.0% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | 2.2% | -22.7% | -348.3% | -122.4% | -69.8% | 191.8% | 489.9% | -128.7% | 122.8% | 35.8% | – | – | – |
| Total equity 3Y CAGR | – | – | – | – | – | 48.3% | 35.6% | – | – | – | – | – | – |
| Total equity 5Y CAGR | – | – | – | – | 17.0% | 58.1% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.